JPS59130213A - 抗腫瘍方法及び組成物 - Google Patents

抗腫瘍方法及び組成物

Info

Publication number
JPS59130213A
JPS59130213A JP58169097A JP16909783A JPS59130213A JP S59130213 A JPS59130213 A JP S59130213A JP 58169097 A JP58169097 A JP 58169097A JP 16909783 A JP16909783 A JP 16909783A JP S59130213 A JPS59130213 A JP S59130213A
Authority
JP
Japan
Prior art keywords
carnitine
acid
tumor
chain fatty
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58169097A
Other languages
English (en)
Japanese (ja)
Inventor
オ−ステイン・エル・シユ−グ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JPS59130213A publication Critical patent/JPS59130213A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58169097A 1982-09-13 1983-09-13 抗腫瘍方法及び組成物 Pending JPS59130213A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41717982A 1982-09-13 1982-09-13
US417179 1982-09-13

Publications (1)

Publication Number Publication Date
JPS59130213A true JPS59130213A (ja) 1984-07-26

Family

ID=23652899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58169097A Pending JPS59130213A (ja) 1982-09-13 1983-09-13 抗腫瘍方法及び組成物

Country Status (4)

Country Link
JP (1) JPS59130213A (fr)
BE (1) BE897738A (fr)
CA (1) CA1228819A (fr)
IT (1) IT1169460B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60178816A (ja) * 1984-02-24 1985-09-12 Rikagaku Kenkyusho 制癌剤
JP2002521428A (ja) * 1998-07-30 2002-07-16 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Ｌ−カルニチンおよびそのアルカノイル誘導体の、抗癌作用を有する医薬品の製造のための使用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316652B1 (en) * 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
DE602004016385D1 (de) 2003-12-24 2008-10-16 Nutricia Nv Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60178816A (ja) * 1984-02-24 1985-09-12 Rikagaku Kenkyusho 制癌剤
JP2002521428A (ja) * 1998-07-30 2002-07-16 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Ｌ−カルニチンおよびそのアルカノイル誘導体の、抗癌作用を有する医薬品の製造のための使用

Also Published As

Publication number Publication date
IT8322785A1 (it) 1985-03-06
IT1169460B (it) 1987-05-27
BE897738A (fr) 1984-01-02
CA1228819A (fr) 1987-11-03
IT8322785A0 (it) 1983-09-06

Similar Documents

Publication Publication Date Title
Newmark et al. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status
JP2824917B2 (ja) 抗腫瘍剤
NZ238179A (en) Composition containing transforming growth factor-bet1(tgf-beta1) and a polyunsaturated fatty acid
JP2568286B2 (ja) メラトニン又はその同族体を含有する代謝老化防止剤
McAndrew Fat metabolism and cancer
WO2016163082A1 (fr) Agent prophylactique/thérapeutique pour infections virales comprenant un composé ala
JP3098544B2 (ja) サイトカイン活性増強剤およびサイトカインの働きが低下した疾病の治療剤
US4883661A (en) Use of arginine as an lymphokine synergist
KR20120084287A (ko) 항산화 조성물
CA2361070A1 (fr) Complement nutritionnel ou preparation pharmaceutique contenant des triglycerides comportant sept atomes de carbone
WO1993010792A1 (fr) Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs
EP1426047A1 (fr) Composition pharmaceutique antitumorale comprenant un amide N-vanillylique d'acide gras
WO1994018965A1 (fr) Utilisation therapeutique de carboxylate de pyrrolidone de pyridoxine
JPS59130213A (ja) 抗腫瘍方法及び組成物
EP0768084A1 (fr) Inhibiteur de la metastase cancereuse
JPH0228319B2 (fr)
CN114522158A (zh) 用于制备治疗肝癌药物的代谢物及其应用
US4898886A (en) Urea against adenocarcinoma
WO2025088121A1 (fr) Polythérapie du cancer métabolique-enzymatique
JPH0653670B2 (ja) 化学療法剤の副作用低減化剤
CA2107371A1 (fr) Methode d'inhibition de la fibrose
JPH05508769A (ja) 細胞培養及び治療に有用なβ―アレチン
Jurin et al. Porcine splenic peptides (Polyerga) decrease the number of experimental lung metastases in mice
US5118624A (en) Method for the stimulation of cell growth and the inhibition of cell proliferation by the utilization of selenodithiols such as selenodiglutathione
Levy et al. Effect of ethionine on the free amino acids in liver of tumorous and nontumorous rats